Clinical Trial: Biologic Augmentation of Osteochondral Allograft Transplantation in the Knee

U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07909928) titled 'Biologic Augmentation of Osteochondral Allograft Transplantation in the Knee' on Oct. 26.

Brief Summary: This prospective, single-center pilot study will evaluate biologic augmentation during osteochondral allograft transplantation of the knee using a combination of bone marrow aspirate concentrate (BMAC) and Arthrex AlloSync Pure.

Approximately 10 adults undergoing osteochondral allograft transplantation for focal osteochondral defects of the medial or lateral femoral condyle will be enrolled. During surgery, BMAC will be collected from the tibial tubercle and mixed with Arthrex AlloSync Pure. The mixture will be applied to the rec...